First African Approvals For Merck’s Ebola Vaccine
A Collaborative Effort Has Secured Rapid Licensing
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.
You may also be interested in...
Following its recent EU approval, moves are under way to make Merck’s Ervebo vaccine available in countries at risk of Ebola.
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.
The US company is bringing extra supplies of lopinavir/ritonavir into France but stresses that the combination treatment is not authorized for treating patients with the coronavirus.